Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
FDA grants Emergency Use Authorizations for two new animal drugs to treat New World screwworm infestations in dogs and puppies. Elanco US Inc. is the requesting company for these treatments targeting myiasis caused by Cochliomyia hominivorax.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.